Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
12/2005
12/14/2005EP1603586A1 14-3-3 protein for prevention and treatment of fibroproliferative disorders
12/14/2005EP1603560A1 Topical immunotherapy and compositions for use therein
12/14/2005EP1603542A1 Treatment and/or prevention of non-viral epithelial damage
12/14/2005EP1603517A1 Skin care product containing tall oil fatty acids and vegetable oils for dry and scaling skin and treatment of psoriasis, dermatitis, and eczemas
12/14/2005EP1603499A2 Invisible patch for the controlled delivery of cosmetic, dermatological, and pharmaceutical active ingredients onto the skin
12/14/2005EP1527084A4 Promoters exhibiting endothelial cell specificity and methods of using same
12/14/2005EP1427709B1 3-substituted-4-pyrimidone derivatives
12/14/2005EP1296669B1 Combination preparation consisting of omega-3-fatty acids and of conjugated linoleic acids for treating immunologically oriented clinical signs
12/14/2005EP1267803B1 Compositions and methods for treating hair loss using c16 - c20 aromatic tetrahydro prostaglandins
12/14/2005EP1242104B1 Process of obtaining thylakoids from plants, pure thylakoids and use thereof
12/14/2005EP1222175B1 4,5-disubstituted-2-aminopyrimidines
12/14/2005EP1127121B1 Construction d'une retrovirus exprimant le locus mel de streptomyces, et son expression dans des cellules mammiferes
12/14/2005EP1112255B1 4,4-biarylpiperidine derivatives with opioid receptor activity
12/14/2005EP1107812B1 Gelatinous body protection article having a therapeutic additive
12/14/2005EP1007047B1 Use of mizolastine for preparing a medicine for treating inflammation
12/14/2005CN1708331A Formulations containing melatonin, ginkgo biloba, and biotin
12/14/2005CN1708313A Organic extract for Japonicum Thunb and application thereof
12/14/2005CN1708301A Daily melatonin dosing units
12/14/2005CN1708300A Peroral preparation for prevention of or treatment for atopic dermatitis
12/14/2005CN1708283A Skin preparations for external use
12/14/2005CN1706838A Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
12/14/2005CN1706824A Compound as CCR5 agonist
12/14/2005CN1706378A Composition for treating inflammation which contains zinc pyrrolidonecarboxylate
12/14/2005CN1231483C 8-Azabicyclo [3.,2.1] Oct-2-Ene and-Octane derivatives
12/14/2005CN1231474C Salts of aiso thiazole-4-carboxamide and their use as anti-hyperproliferatin agents
12/14/2005CN1231471C 4-amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhbitors of cell-cycle kinases
12/14/2005CN1231464C Novel 3-substituted urea derivatives and medicinal use thereof
12/14/2005CN1231459C Novel aminobenzophenones
12/14/2005CN1231238C Chinese medicine for inflammation and swelling
12/14/2005CN1231231C Ointment for treating burns and scalds and its prepn.
12/14/2005CN1231230C Apoplexy treating capsule and its preparation method
12/14/2005CN1231228C Drug moxibustion product with effect of promoting flow of qi and blood circulation and assuaging pain
12/14/2005CN1231212C Multicyclic compounds which inhibit beukocyte adhesion mediated by VLA-4
12/13/2005US6974836 Diamines as modulators of chemokine receptor activity
12/13/2005US6974831 sPLA2 inhibitors
12/13/2005US6974828 3-((2-((3-((Amino(imino)methyl)amino)benzoyl)amino)phenyl)sulf anyl)- 3-(3-pyridinyl)propanoic acid, for example; angiogenic inhibitors; antitumor, -carcinogenic, -metastatic, -diabetic, -arthritic and inflammatory agents; bone disorders
12/13/2005US6974823 Hydantoin derivative compounds, pharmaceutical compositions, and methods of using same
12/13/2005US6974819 Alzheimer's disease; Parkinson's disease; Pick's disease; bipolar disorders; schizophrenia; alopecia; anticancer agents
12/13/2005US6974809 Inhibitors of interleukin 1-β converting enzyme
12/13/2005US6974807 administering topically to alleviate proliferative skin diease; nontoxic
12/13/2005US6974596 Comprising cedrol, cedrenol, farnesol, patchouli alcohol or vetiverol; antiallergic agents and atopic dermatitis preventives
12/13/2005US6974594 Method of preparing biological materials and preparations produced using same
12/13/2005US6974583 Used to prevent or combat the harmful effects of UV and/or pollution on the skin, loss of firmness and/or elasticity of the skin, etc.
12/13/2005CA2280151C Arylsulfonyl hydroxamic acid derivatives
12/13/2005CA2278521C Two phase skin preparations comprising lipophilic and hydrophilic components
12/13/2005CA2234066C Substituted imidazoles having anti-cancer and cytokine inhibitory activity
12/10/2005CA2507847A1 Prostaglandin reductase
12/10/2005CA2507738A1 Modulation of peroxisome proliferator-activated receptors
12/08/2005WO2005116067A2 Msh-agonist tripeptide conjugates
12/08/2005WO2005116053A1 Novel hair growth stimulant
12/08/2005WO2005115460A1 A method of producing polypeptides from plant protein and use of polypeptides
12/08/2005WO2005115402A1 Use of a combination of ethinyl estradiol and chlormadinone acetate for the production of a medicament
12/08/2005WO2005115365A2 Pharmaceutical or cosmetic composition comprising mequinol and at least one depigmenting agent
12/08/2005WO2005115324A1 Dermatological composition for the treatment of pigmentary disorders of the skin
12/08/2005WO2005115323A1 Mequinol-based dermatological depigmenting composition
12/08/2005WO2005074968A3 Medical use of basic peptides
12/08/2005WO2002066494A3 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade
12/08/2005US20050272936 Imidazolium cxcr3 inhibitors
12/08/2005US20050272931 Vanilloid receptor ligands and their use in treatments
12/08/2005US20050272922 Processes for preparing crosslinker-free, biopolymer-containing three dimensional structures, and products prepared thereby
12/08/2005US20050272817 Dermatological use and a dermatological preparation
12/08/2005US20050272789 Triazole-derived kinase inhibitors and uses thereof
12/08/2005US20050272783 Amino acids with affinity for the alpha2delta-protein
12/08/2005US20050272761 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders
12/08/2005US20050272750 Novel compound
12/08/2005US20050272709 tert-butyl-[5-methyl-4-(phenylhydrazono)-4H-pyrazol-3-yl]amine; 4-(3-fluorophenylhydrazono)-5-methyl-2H-pyrazol-3-ylamine; demonstrate anti-proliferative activity, and may promote apoptosis in cells lacking normal regulation of cell cycle and death
12/08/2005US20050272708 phosphoinositol ether lipid analogues and bioisosteres thereof;serine/threonine kinase (protein kinase B (PKB)) inhibitor; antitumor and anticarcinogenic agent; decreasing phosphorylation, increasing apoptosis in a tumor cell, and inhibiting pleckstrin homology (PH) domain binding
12/08/2005US20050272694 Composition containing beta-glucan and constipation-relieving drug, immunopotentiatior, and skin moistening agent using the composition
12/08/2005US20050272148 Method of collecting placental stem cells
12/08/2005US20050272077 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
12/08/2005US20050271751 Active principle which is capable of inducing the conversion of inactive TGFb-latent into active TGFb
12/08/2005US20050271750 Topical formulation for prevention and treatment of acne
12/08/2005US20050271743 Treatment of inflammatory skin conditions
12/08/2005US20050271632 Methods of modulating hair growth
12/08/2005US20050271606 Composition for treating inflammation which contains zinc pyrrolidonecarboxylate
12/08/2005US20050271604 Matrix protein compositions for wound healing
12/08/2005CA2824612A1 Compounds, formulations, and methods for treating or preventing inflammatory skin disorders
12/08/2005CA2565805A1 Msh-agonist tripeptide conjugates
12/08/2005CA2564104A1 Pharmaceutical or cosmetic composition comprising mequinol and at least one depigmenting agent
12/08/2005CA2564100A1 Dermatological composition for the treatment of pigmentary disorders of the skin
12/08/2005CA2564077A1 Mequinol-based dermatological depigmenting composition
12/08/2005CA2562565A1 Spot-on formulation useful for cosmetology and dermatology
12/07/2005EP1602704A1 Antioxidant, skin preparation for external use, cosmetic and food
12/07/2005EP1602669A1 Antibody against tumor specific antigen as target
12/07/2005EP1602660A1 Aminophosphonic acid derivatives, addition salts thereof and s1p receptor modulators
12/07/2005EP1602656A1 Pyrazole derivatives having affinity for cb1 and/or cb2 receptors
12/07/2005EP1602647A1 Novel compound having 4-pyridylalkylthio group as substituent
12/07/2005EP1602379A1 Botulinum toxin B for treating spastic muscle
12/07/2005EP1602377A1 Composition containing beta-glucan and constipation-relieving drug, immunopotentiator and skin moistening agent using the composition
12/07/2005EP1602368A2 Cdc25 phosphatase inhibitors
12/07/2005EP1601673A1 Novel fused heterocycles and uses thereof
12/07/2005EP1601369A1 Oil compositions obtained from non-heated plant parts, introduced ground and non-heated in the press, extracted by cold pressing
12/07/2005EP1496917B1 Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders
12/07/2005EP1430073B1 Solvent extraction process
12/07/2005EP1425381A4 Emu-based formulations for wound treatment related application information
12/07/2005EP1379528A4 Pyrazolopyrimidines as therapeutic agents
12/07/2005EP1353904B1 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands
12/07/2005EP1330164B1 Antibacterial agents and antibacterial and deodorizing solution comprising the same
12/07/2005EP1307449B1 1,4-dihydropyridines as bradykinin antagonists
12/07/2005EP1303269B1 Use of 3-substituted oxindole derivatives as kcnq potassium channel modulators
1 ... 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 ... 1065